- Community-Beiträge
- Aktuellste Threads
| Geld/Brief | 5,90 € / 6,00 € |
| Spread | +1,69% |
| Schluss Vortag | 5,95 € |
| Gehandelte Stücke | 0 |
| Tagesvolumen Vortag | - |
| Tagestief 5,95 € Tageshoch 5,95 € | |
| 52W-Tief 4,50 € 52W-Hoch 7,75 € | |
| Jahrestief 4,50 € Jahreshoch 6,45 € | |
| Umsatz in Mio. | 335,71 $ |
| Operatives Ergebnis (EBIT) in Mio. | -42,52 $ |
| Jahresüberschuss in Mio. | -35,89 $ |
| Umsatz je Aktie | 14,19 $ |
| Gewinn je Aktie | -1,52 $ |
| Gewinnrendite | -20,64% |
| Umsatzrendite | - |
| Return on Investment | -12,12% |
| Marktkapitalisierung in Mio. | 216,91 $ |
| KGV (Kurs/Gewinn) | -6,03 |
| KBV (Kurs/Buchwert) | 1,25 |
| KUV (Kurs/Umsatz) | 0,65 |
| Eigenkapitalrendite | - |
| Eigenkapitalquote | +58,70% |
| 30.06.2026 | Quartalsmitteilung |
| Handelsplatz | Letzter | Änderung | Vortag | Zeit | |
|---|---|---|---|---|---|
| Düsseldorf | 5,85 € | +0,86% | 5,80 € | 09:32 | |
| Frankfurt | 5,90 € | +3,51% | 5,70 € | 08:00 | |
| Stuttgart | 5,90 € | +6,31% | 5,55 € | 11:33 | |
| L&S RT | 5,95 € | +0,42% | 5,925 € | 12:25 | |
| NYSE | 6,76 $ | +3,52% | 6,53 $ | 24.06.26 | |
| Nasdaq | 6,75 $ | 0 % | 6,75 $ | 24.06.26 | |
| AMEX | 6,76 $ | - | - | 24.06.26 | |
| Tradegate | 5,60 € | -5,88% | 5,95 € | 17.06.26 | |
| Quotrix | 5,95 € | +3,48% | 5,75 € | 07:56 | |
| Gettex | 5,95 € | 0 % | 5,95 € | 12:13 | |
| Datum | Kurs | Volumen |
|---|---|---|
| 24.06.26 | 5,95 | 0 |
| 23.06.26 | 5,70 | 0 |
| 22.06.26 | 5,70 | 0 |
| 19.06.26 | 5,60 | 0 |
| 18.06.26 | 5,60 | 4.752 |
| Zeitraum | Kurs | % |
|---|---|---|
| 1 Woche | 5,60 € | +6,25% |
| 1 Monat | 5,50 € | +8,18% |
| 6 Monate | 5,65 € | +5,31% |
| 1 Jahr | 6,00 € | -0,83% |
| 5 Jahre | - | - |
| Streubesitz | 10,34% |
| Land | USA |
| Sektor | Gesundheit |
| Branche | Gesundheitswesen: Ausstattung u. Produkte |
| Aktientyp | Stammaktie |
| +6,27% | BlackRock Inc |
| +5,20% | Vanguard Group Inc |
| +4,39% | Armistice Capital, LLC |
| +3,96% | Acadian Asset Management LLC |
| +3,14% | Ameriprise Financial Inc |
| +3,09% | Dafna Capital Management LLC |
| +2,24% | Geode Capital Management, LLC |
| +2,14% | Arrowstreet Capital Limited Partnership |
| +2,12% | The Goldman Sachs Group Inc |
| +2,09% | State Street Corp |
| +2,01% | Royce & Associates, LP |
| +1,98% | Morgan Stanley - Brokerage Accounts |
| +1,86% | Dimensional Fund Advisors, Inc. |
| +1,77% | Federated Hermes Inc |
| +1,75% | Renaissance Technologies Corp |
| +1,56% | JPMorgan Chase & Co |
| +1,51% | CSM Advisors, LLC |
| +1,51% | Nuveen, LLC |
| +1,35% | Prudential Financial Inc |
| +1,09% | Jacobs Levy Equity Management, Inc. |
| +38,63% | Weitere |
| +10,34% | Streubesitz |
Zahlen für Q2/20
Mittlerweile auf einem interessanten Bewertungsniveau angekommen.
https://investor.inogen.com/news-events/press-releases/detail/157/inogen-announces-second-quarter-2020-financial-results
Zahlen für Q1/20
" Inogen is withdrawing its previously announced full year 2020 guidance issued on February 25, 2020 as the Company is unable to estimate the scope, duration, and impact of the COVID-19 PHE for full year 2020. The Company believes it could continue to see a decline in sales in its direct-to-consumer channel until patient mobility and consumer confidence increases. The Company also believes the increase in demand that it experienced for its products in the first quarter in its business-to-business channels due to the COVID-19 PHE may be limited or demand may decline in the future as new COPD patient referrals could decline as physician offices are limiting patient interactions. Given the increased uncertainty around the scope, duration, and impact of the COVID-19 PHE as well as revenue mix between direct-to-consumer and business-to-business channels, Inogen cannot estimate the overall impact to its operations and financial results, which could be material. Due to these uncertainties, the Company is implementing cost savings by delaying certain personnel hires and reducing advertising spend, while also increasing rental setups to improve lead utilization."
https://investor.inogen.com/news-events/press-releases/detail/153/inogen-announces-first-quarter-2020-financial-results
